Alpharma
This article was originally published in The Tan Sheet
Executive Summary
Company will ship generic Cromolyn Sodium Nasal Solution USP to several major drugstores in the first half of August, firm says. Alpharma received final approval of ANDA 74-800 for its Nasalcrom equivalent July 26 and is second private labeler to receive FDA clearance; Bausch & Lomb's generic cromolyn sodium was approved in early July (1"The Tan Sheet" July 9, p. 28). Pharmacia's Nasalcrom lost marketing exclusivity July 3, 2000 after receiving six months of pediatric exclusivity
You may also be interested in...
Pfizer BenaMist Launch Delayed By Manufacturing Issues
Pfizer Consumer Healthcare's launch of its BenaMist Allergy Prevention Nasal Spray is being delayed due to production problems faced by contract manufacturer Alpharma, Pfizer said
Pfizer BenaMist Launch Delayed By Manufacturing Issues
Pfizer Consumer Healthcare's launch of its BenaMist Allergy Prevention Nasal Spray is being delayed due to production problems faced by contract manufacturer Alpharma, Pfizer said
Pfizer BenaMist Launch Delayed By Manufacturing Issues
Pfizer Consumer Healthcare's launch of its BenaMist Allergy Prevention Nasal Spray is being delayed due to production problems faced by contract manufacturer Alpharma, Pfizer said